person

Malgorzata S.

Country
Poland
Department
1st Department of Lung Diseases

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
80
Sites with multiple studies

Has run more than one trial at 80 of 188 partner sites.

Specializations

Pulmonary Fibrosis Research

The investigator specializes in studying therapeutic approaches for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), with particular emphasis on innovative treatment solutions for these challenging respiratory conditions.

  • Lung Function Assessment
  • Chronic Cough Management
  • Progressive Disease Monitoring

Their research encompasses evaluation of novel therapeutic compounds for improving respiratory function and quality of life in pulmonary fibrosis patients.

Long-term Treatment Studies

The investigator focuses on conducting extended duration studies to evaluate the sustained effectiveness of treatments for chronic respiratory conditions. Their work includes comprehensive assessment of treatment tolerability and safety profiles over extended periods.

  • Treatment Tolerability
  • Safety Monitoring
  • Extended Efficacy Assessment

Their research emphasizes the importance of long-term therapeutic outcomes in managing progressive respiratory diseases.

Clinical Symptom Management

The investigator specializes in researching targeted symptom management, particularly focusing on chronic cough reduction and improvement of respiratory function in fibrotic lung diseases.

  • Cough Frequency Assessment
  • Dose-Response Evaluation
  • Therapeutic Range Optimization

Their work involves evaluating novel therapeutic approaches for managing specific symptoms associated with pulmonary fibrosis.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.